首页 > 最新文献

Endocrinologia Diabetes Y Nutricion最新文献

英文 中文
Evaluation of plasma cortisol during fasting test in patients with endogenous hyperinsulinemic hypoglycemia. Fifteen years experience 内源性高胰岛素血症性低血糖患者空腹试验期间血浆皮质醇的评价。15年的工作经验。
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1016/j.endien.2023.11.008
María Eugenia Gullace , María Victoria Ortuño , Teresa Mabel Canteros , Belén Bosco , Cintia Rodriguez , Javier Giunta , Lucas Costa , Andrea Kozak , Valeria de Miguel , Luis Grosembacher

Background

Endogenous hyperinsulinemic hypoglycemia (EHH) is a rare clinical condition. The aim of this study was to evaluate baseline plasma cortisol concentration and its concentration during hypoglycemic crisis in fasting tests (FT) performed in our center. Secondarily, the aim was to establish the relationship between baseline cortisol and the time of evolution of EHH.

Material and methods

A retrospective, observational, descriptive study was carried out which included patients with hypoglycemic disorder with positive FT.

Results

Of a total of 21 patients, 16 presented insulinoma, 1 nesidioblastosis, 2 malignant insulinoma and 2 EHH without pathological diagnosis. The time from the onset of symptoms to diagnosis was 2 years (Q1 = 1.5–Q2 = 5.5). The comparison between median baseline cortisol (BC) = 11.8 mcg/dl (nmol/L 340.68) (Q1 = 9–Q3 = 14.1) and median cortisol during hypoglycemic episode (HC) = 11.6 mcg/dl (nmol/L: 303.44) (Q1 = 7.8–Q3 = 16.1) showed no differences (Z = −0.08; P > .05). When correlating BC with HC, no significant relationship was observed (r = 0.16; P > .05). When correlating the glycemic value in the crisis and the HC, a slight negative trend was found (r = −0.53; P = .01). In addition, we found that recurrent hypoglycemic disorder is associated with lower baseline cortisol values ​​the longer the time of its evolution.

Conclusion

We confirmed that cortisol values ​​remain low during hypoglycemic episodes, reinforcing the hypothesis of lack of response of this counterregulatory hormone in cases of recurrent hypoglycemia.

背景:内源性高胰岛素性低血糖症(EHH)是一种罕见的临床疾病。本研究的目的是评估基线血浆皮质醇浓度及其在我们中心进行的空腹试验(FT)中的低血糖危机期间的浓度。其次,目的是建立基线皮质醇与EHH进化时间之间的关系。材料与方法:采用回顾性、观察性、描述性的研究方法,纳入ft阳性的低血糖障碍患者。结果:共21例患者中,16例出现胰岛素瘤,1例出现nesidioblastosis, 2例出现恶性胰岛素瘤,2例无病理诊断的EHH。从症状出现到诊断的时间为2年(Q1=1.5-Q2=5.5)。基线皮质醇中位数(BC)=11.8 mcg/dl (nmol/L 340.68) (Q1=9-Q3=14.1)与低血糖发作期间皮质醇中位数(HC)=11.6 mcg/dl (nmol/L: 303.44) (Q1=7.8-Q3=16.1)比较无差异(Z=-0.08;(P > . 05)。当将BC与HC相关联时,未观察到显著相关性(r=0.16;(P > . 05)。危机期血糖值与HC相关时,发现有轻微的负向趋势(r=-0.53;P = . 01)。此外,我们发现复发性低血糖障碍与病程越长基线皮质醇值越低有关。结论:我们证实,在低血糖发作期间,皮质醇值仍然很低,这加强了这种反调节激素在反复低血糖病例中缺乏反应的假设。
{"title":"Evaluation of plasma cortisol during fasting test in patients with endogenous hyperinsulinemic hypoglycemia. Fifteen years experience","authors":"María Eugenia Gullace ,&nbsp;María Victoria Ortuño ,&nbsp;Teresa Mabel Canteros ,&nbsp;Belén Bosco ,&nbsp;Cintia Rodriguez ,&nbsp;Javier Giunta ,&nbsp;Lucas Costa ,&nbsp;Andrea Kozak ,&nbsp;Valeria de Miguel ,&nbsp;Luis Grosembacher","doi":"10.1016/j.endien.2023.11.008","DOIUrl":"10.1016/j.endien.2023.11.008","url":null,"abstract":"<div><h3>Background</h3><p><span>Endogenous hyperinsulinemic hypoglycemia<span> (EHH) is a rare clinical condition. The aim of this study was to evaluate baseline plasma cortisol concentration and its concentration during </span></span>hypoglycemic crisis in fasting tests (FT) performed in our center. Secondarily, the aim was to establish the relationship between baseline cortisol and the time of evolution of EHH.</p></div><div><h3>Material and methods</h3><p>A retrospective, observational, descriptive study was carried out which included patients with hypoglycemic disorder with positive FT.</p></div><div><h3>Results</h3><p><span>Of a total of 21 patients, 16 presented insulinoma, 1 nesidioblastosis, 2 malignant insulinoma and 2 EHH without pathological diagnosis. The time from the onset of symptoms to diagnosis was 2 years (Q1</span> <!-->=<!--> <!-->1.5–Q2<!--> <!-->=<!--> <!-->5.5). The comparison between median baseline cortisol (BC)<!--> <!-->=<!--> <!-->11.8 mcg/dl (nmol/L 340.68) (Q1<!--> <!-->=<!--> <!-->9–Q3<!--> <!-->=<!--> <!-->14.1) and median cortisol during hypoglycemic episode (HC)<!--> <!-->=<!--> <!-->11.6 mcg/dl (nmol/L: 303.44) (Q1<!--> <!-->=<!--> <!-->7.8–Q3<!--> <!-->=<!--> <!-->16.1) showed no differences (Z<!--> <!-->=<!--> <!-->−0.08; <em>P</em> <!-->&gt;<!--> <!-->.05). When correlating BC with HC, no significant relationship was observed (r<!--> <!-->=<!--> <!-->0.16; <em>P</em> <!-->&gt;<!--> <span>.05). When correlating the glycemic value in the crisis and the HC, a slight negative trend was found (r</span> <!-->=<!--> <!-->−0.53; <em>P</em> <!-->=<!--> <!-->.01). In addition, we found that recurrent hypoglycemic disorder is associated with lower baseline cortisol values ​​the longer the time of its evolution.</p></div><div><h3>Conclusion</h3><p>We confirmed that cortisol values ​​remain low during hypoglycemic episodes, reinforcing the hypothesis of lack of response of this counterregulatory hormone in cases of recurrent hypoglycemia.</p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 10","pages":"Pages 634-639"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138452860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-transplant diabetes mellitus: Findings in nutritional status and body composition 移植后糖尿病:营养状况和身体成分的调查结果
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1016/j.endien.2023.10.005
Laura Pereira Barretto, Patrícia Moreira Gomes, Natália Rossin Guidorizzi, Miguel Moyses Neto, Elen Almeida Romao, Paula Garcia Chiarello

Introduction

Weight gain and changes in body composition are associated with the onset of diabetes after kidney transplantation, and detailing these changes can help prevent this situation. The study aimed to assess the prevalence of diabetes mellitus after kidney transplantation and changes in the nutritional status and body composition in patients with diabetes one year from surgery.

Materials and methods

This survey was a single-center, prospective cohort study. Twenty-nine patients over 18 years old who underwent isolated kidney transplantation, without diabetes, were included and followed up for one year. At hospital discharge after transplantation and one year later, anthropometric (weight, height and abdominal circumference), body composition (electrical bioimpedance), routine biochemical and dietary intake assessments were performed.

Results

Most of the patients were male (75%), and the mean age was 48.0 ± 11.8 years old. In the first-year post-surgery 27.6% of patients had DM and the diagnosis was made, on average, 4 months after transplantation. The group with diabetes had, from the beginning to the end of the study, greater weight and body fat, especially abdominal fat. The non-diabetic group, after one year, showed an increase in phase angle, body weight and body masses, more pronounced of fat-free mass, when compared with fat mass gain.

Conclusions

Both groups showed weight gain, but in the non-diabetic group these changes can be interpreted as an improvement in the nutritional profile. Metabolic abnormalities associated with immunosuppression and eating habits, combination that maintains increased the risk for diabetes for long time, keeping this group with priority in nutritional care.

简介:体重增加和身体成分的变化与肾移植后糖尿病的发病有关,详细了解这些变化有助于预防这种情况的发生。本研究旨在评估肾移植术后糖尿病的患病率以及术后一年糖尿病患者营养状况和身体成分的变化。研究纳入了 29 名 18 岁以上接受孤立肾移植且未患糖尿病的患者,并对其进行了为期一年的随访。移植后出院时和一年后,对患者进行人体测量(体重、身高和腹围)、身体成分(生物电阻抗)、常规生化指标和饮食摄入评估。术后第一年,27.6%的患者患有糖尿病,平均在移植后 4 个月确诊。从研究开始到结束,糖尿病组患者的体重和体脂都有所增加,尤其是腹部脂肪。结论两组患者的体重都有所增加,但非糖尿病组的这些变化可以解释为营养状况的改善。新陈代谢异常与免疫抑制和饮食习惯有关,这两种因素长期结合在一起会增加患糖尿病的风险,因此这组患者应优先得到营养护理。
{"title":"Post-transplant diabetes mellitus: Findings in nutritional status and body composition","authors":"Laura Pereira Barretto,&nbsp;Patrícia Moreira Gomes,&nbsp;Natália Rossin Guidorizzi,&nbsp;Miguel Moyses Neto,&nbsp;Elen Almeida Romao,&nbsp;Paula Garcia Chiarello","doi":"10.1016/j.endien.2023.10.005","DOIUrl":"https://doi.org/10.1016/j.endien.2023.10.005","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Weight gain and changes in body composition are associated with the onset of diabetes after kidney transplantation, and detailing these changes can help prevent this situation. The study aimed to assess the prevalence of diabetes mellitus after kidney transplantation and changes in the nutritional status and body composition </span>in patients with diabetes one year from surgery.</p></div><div><h3>Materials and methods</h3><p><span><span>This survey was a single-center, prospective cohort study. Twenty-nine patients over 18 years old who underwent isolated kidney transplantation, without diabetes, were included and followed up for one year. At hospital discharge after transplantation and one year later, </span>anthropometric (weight, height and abdominal circumference), body composition (electrical bioimpedance), routine biochemical and </span>dietary intake assessments were performed.</p></div><div><h3>Results</h3><p>Most of the patients were male (75%), and the mean age was 48.0<!--> <!-->±<!--> <span>11.8 years old. In the first-year post-surgery 27.6% of patients had DM and the diagnosis was made, on average, 4 months after transplantation. The group with diabetes had, from the beginning to the end of the study, greater weight and body fat, especially abdominal fat. The non-diabetic group, after one year, showed an increase in phase angle, body weight and body masses, more pronounced of fat-free mass, when compared with fat mass gain.</span></p></div><div><h3>Conclusions</h3><p>Both groups showed weight gain, but in the non-diabetic group these changes can be interpreted as an improvement in the nutritional profile<span>. Metabolic abnormalities associated with immunosuppression and eating habits, combination that maintains increased the risk for diabetes for long time, keeping this group with priority in nutritional care.</span></p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 10","pages":"Pages 628-633"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138549520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opinion of primary care physicians on the use of continuous glucose monitoring in type 2 diabetes 初级保健医生对2型糖尿病患者持续血糖监测的看法
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1016/j.endien.2023.11.009
Domingo Orozco-Beltrán , Fernando Alvarez-Guisasola , Flora López-Simarro , Carlos Miranda-Fernández-Santos , Antonio Pérez Pérez
{"title":"Opinion of primary care physicians on the use of continuous glucose monitoring in type 2 diabetes","authors":"Domingo Orozco-Beltrán ,&nbsp;Fernando Alvarez-Guisasola ,&nbsp;Flora López-Simarro ,&nbsp;Carlos Miranda-Fernández-Santos ,&nbsp;Antonio Pérez Pérez","doi":"10.1016/j.endien.2023.11.009","DOIUrl":"10.1016/j.endien.2023.11.009","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 10","pages":"Pages 656-658"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138435264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of hypoglycemia in a patient with type 1 diabetes mellitus: A little-known adverse effect of linezolid 1型糖尿病患者低血糖的发生:利奈唑胺鲜为人知的不良反应
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1016/j.endien.2023.11.006
Raquel Niddam, Fernando Vidal-Ostos de Lara, Jhamil Zurita-Campos, Concepción Blanco-Carrera, Jose Antonio Rubio
{"title":"Development of hypoglycemia in a patient with type 1 diabetes mellitus: A little-known adverse effect of linezolid","authors":"Raquel Niddam,&nbsp;Fernando Vidal-Ostos de Lara,&nbsp;Jhamil Zurita-Campos,&nbsp;Concepción Blanco-Carrera,&nbsp;Jose Antonio Rubio","doi":"10.1016/j.endien.2023.11.006","DOIUrl":"10.1016/j.endien.2023.11.006","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 10","pages":"Pages 654-656"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138463777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normocalcemic hyperparathyroidism after successful parathyroidectomy for single parathyroid adenoma: Prevalence, etiological factors, predictive markers, treatment and evolution 单发甲状旁腺瘤成功切除后的甲状旁腺功能亢进:患病率、病因、预测指标、治疗和演变。
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1016/j.endien.2023.11.007
Luis García Pascual , Andreu Simó-Servat , Carlos Puig-Jové , Lluís García-González

Background and objective

Postparathyroidectomy normocalcemic hyperparathyroidism (PPNCHPPT) is a frequent situation for which we have no information in our country. The objective is to know our prevalence of PPNCHPPT, the associated etiological factors, the predictive markers, the treatment administered and the evolution.

Patients and method

Retrospective observational cross-sectional study on 42 patients. Twelve patients with PPNCHPPT and 30 without PPNCHPPT are compared.

Results

HPPTNCPP prevalence: 28.6%. Etiological factors: vitamin D deficiency: 75%; bone remineralization: 16.7%; renal failure: 16.7%; hypercalciruria: 8.3%. No change in the set point of calcium-mediated parathormone (PTH) secretion was observed, but an increase in the preoperative PTH/albumin-corrected calcium (ACC) ratio was observed. Predictive markers: PTH/ACC ratio (AUC 0.947; sensitivity 100%, specificity 78.9%) and PTH (AUC 0.914; sensitivity 100%, specificity 73.7%) one week postparathyroidectomy. Evolution: follow-up 30 ± 16.3 months: 50% normalized PTH and 8.3% had recurrence of hyperparathyroidism. Patients with PPNCHPPT less frequently received preoperative treatment with bisphosphonates and postoperative treatment with calcium salts.

Conclusions

This is the first study in our country that demonstrates a mean prevalence of PPNCHPPT, mainly related to a vitamin D deficiency and a probable resistance to the action of PTH, which can be predicted by the PTH/ACC ratio and PTH a week post-intervention and often evolves normalizing the PTH. We disagree with the etiological effect of hypercalciuria and the change in the PTH/calcemia regulation set point, and we acknowledge the scant treatment administered with calcium salts in the postoperative period.

背景与目的:甲状旁腺切除术后正常钙血症性甲状旁腺功能亢进(PPNCHPPT)是一种常见病,在我国尚无相关资料。目的是了解我们的PPNCHPPT的患病率,相关的病因,预测指标,给予的治疗和演变。患者与方法:42例患者的回顾性观察性横断面研究。将12例PPNCHPPT患者与30例非PPNCHPPT患者进行比较。结果:HPPTNCPP患病率为28.6%。病因:维生素D缺乏:75%;骨再矿化:16.7%;肾功能衰竭:16.7%;hypercalciruria: 8.3%。观察到钙介导的甲状旁腺激素(PTH)分泌设定值没有变化,但术前PTH/白蛋白校正钙(ACC)比值升高。预测指标:PTH/ACC比值(AUC 0.947;敏感性100%,特异性78.9%)和PTH (AUC 0.914;敏感性100%,特异性73.7%)甲状旁腺切除术后一周。进展:随访30 ± 16.3个月:50%甲状旁腺功能正常,8.3%甲状旁腺功能亢进复发。PPNCHPPT患者术前较少使用双膦酸盐治疗,术后使用钙盐治疗。结论:这是我国第一个证明PPNCHPPT平均患病率的研究,主要与维生素D缺乏和对甲状旁腺激素作用的可能抵抗有关,这可以通过干预后一周的PTH/ACC比率和PTH来预测,并且通常会使PTH正常化。我们不同意高钙尿的病因作用和PTH/钙血症调节设定点的变化,我们承认术后钙盐治疗不足。
{"title":"Normocalcemic hyperparathyroidism after successful parathyroidectomy for single parathyroid adenoma: Prevalence, etiological factors, predictive markers, treatment and evolution","authors":"Luis García Pascual ,&nbsp;Andreu Simó-Servat ,&nbsp;Carlos Puig-Jové ,&nbsp;Lluís García-González","doi":"10.1016/j.endien.2023.11.007","DOIUrl":"10.1016/j.endien.2023.11.007","url":null,"abstract":"<div><h3>Background and objective</h3><p>Postparathyroidectomy normocalcemic hyperparathyroidism<span><span> (PPNCHPPT) is a frequent situation for which we have no information in our country. The objective is to know our prevalence of PPNCHPPT, the associated etiological factors, the predictive markers, the </span>treatment administered and the evolution.</span></p></div><div><h3>Patients and method</h3><p>Retrospective observational cross-sectional study on 42 patients. Twelve patients with PPNCHPPT and 30 without PPNCHPPT are compared.</p></div><div><h3>Results</h3><p><span><span>HPPTNCPP prevalence: 28.6%. Etiological factors: vitamin D<span> deficiency: 75%; bone remineralization: 16.7%; renal failure: 16.7%; hypercalciruria: 8.3%. No change in the set point of calcium-mediated parathormone (PTH) secretion was observed, but an increase in the preoperative PTH/albumin-corrected calcium (ACC) ratio was observed. Predictive markers: PTH/ACC ratio (AUC 0.947; sensitivity 100%, specificity 78.9%) and PTH (AUC 0.914; sensitivity 100%, specificity 73.7%) one week postparathyroidectomy. Evolution: follow-up 30 ± 16.3 months: 50% normalized PTH and 8.3% had recurrence of hyperparathyroidism. Patients with PPNCHPPT less frequently received </span></span>preoperative treatment with </span>bisphosphonates<span> and postoperative treatment with calcium salts.</span></p></div><div><h3>Conclusions</h3><p><span>This is the first study in our country that demonstrates a mean prevalence of PPNCHPPT, mainly related to a vitamin D deficiency and a probable resistance to the action of PTH, which can be predicted by the PTH/ACC ratio and PTH a week post-intervention and often evolves normalizing the PTH. We disagree with the etiological effect of hypercalciuria and the change in the PTH/calcemia regulation set point, and we acknowledge the scant treatment administered with calcium salts in the </span>postoperative period.</p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 10","pages":"Pages 640-648"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138435263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How do we choose the most appropriate clinical guidelines? 我们如何选择最合适的临床指南?
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-01 DOI: 10.1016/j.endien.2023.05.017
Mercè Fernández Balsells
{"title":"How do we choose the most appropriate clinical guidelines?","authors":"Mercè Fernández Balsells","doi":"10.1016/j.endien.2023.05.017","DOIUrl":"10.1016/j.endien.2023.05.017","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 9","pages":"Pages 561-563"},"PeriodicalIF":1.9,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89720045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous ethanol injection in thyroid nodular pathology and metastatic cervical adenopathies: A systematic review, meta-analysis and economic evaluation 经皮乙醇注射治疗甲状腺结节病理和转移性宫颈腺病:系统回顾、荟萃分析和经济评价。
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-01 DOI: 10.1016/j.endien.2023.08.007
Beatriz León-Salas , Aránzazu Hernández-Yumar , Diego Infante-Ventura , Aythami de Armas Castellano , Yadira González Hernández , Renata Linertová , Teresa Téllez Santana , Pedro de Pablos-Velasco , María M. Trujillo-Martín

Background

Percutaneous ethanol injection (PEI) has been shown to be a valuable treatment for thyroid nodular pathology and metastatic cervical adenopathies.

Objective

To evaluate the effectiveness, safety, and cost-effectiveness of PEI in thyroid nodular pathology and metastatic cervical adenopathies.

Methods

A systematic review (SR) using meta-analysis was conducted on the effectiveness and safety of PEI. A SR on cost-effectiveness was also performed. The SRs were conducted according to the methodology developed by the Cochrane Collaboration with reporting in accordance with the PRISMA statement. A cost-minimization analysis was carried out using a decision tree model. Assuming equal effectiveness between two minimally invasive techniques (PEI and radiofrequency ablation (RFA)), the model compared the costs of the alternatives with a horizon of six months and from the perspective of the Spanish National Health System.

Results

The search identified three RCTs (n = 157) that evaluated PEI versus RFA in patients diagnosed with benign thyroid nodules: ninety-six patients with predominantly cystic nodules and sixty-one patients with solid nodules. No evidence was found on other techniques or thyroid nodular pathology. No statistically significant differences were observed between PEI and RFA in volume reduction (%), symptom score, cosmetic score, therapeutic success and major complications. No economic evaluations were identified. The cost-minimization analysis estimated the cost per patient of the PEI procedure at €326 compared to €4781 for RFA, which means an incremental difference of −€4455.

Conclusions

There are no differences between PEI and RFA regarding their safety and effectiveness, but the economic evaluation determined that the former option is cheaper.

背景:经皮乙醇注射(PEI)已被证明是甲状腺结节病理和转移性宫颈腺病的一种有价值的治疗方法。目的:评价PEI在甲状腺结节性病理和转移性宫颈腺病中的有效性、安全性和成本效益。方法:采用meta分析对PEI的有效性和安全性进行系统评价。还对成本效益进行了评估。SRs按照Cochrane协作组制定的方法进行,并按照PRISMA声明进行报告。采用决策树模型进行了成本最小化分析。假设两种微创技术(PEI和射频消融(RFA))的效果相同,该模型从西班牙国家卫生系统的角度比较了六个月的替代方案的成本。结果:本研究确定了3项随机对照试验(n=157),评估了PEI与RFA在诊断为良性甲状腺结节患者中的作用:96例主要为囊性结节,61例为实性结节。其他技术或甲状腺结节病理未发现证据。PEI和RFA在体积缩小(%)、症状评分、美容评分、治疗成功率和主要并发症方面均无统计学差异。没有确定经济评价。成本最小化分析估计PEI手术的每位患者成本为326欧元,而RFA为4781欧元,这意味着增量差异为- 4455欧元。结论:PEI和RFA在安全性和有效性方面没有差异,但经济评估确定前者更便宜。
{"title":"Percutaneous ethanol injection in thyroid nodular pathology and metastatic cervical adenopathies: A systematic review, meta-analysis and economic evaluation","authors":"Beatriz León-Salas ,&nbsp;Aránzazu Hernández-Yumar ,&nbsp;Diego Infante-Ventura ,&nbsp;Aythami de Armas Castellano ,&nbsp;Yadira González Hernández ,&nbsp;Renata Linertová ,&nbsp;Teresa Téllez Santana ,&nbsp;Pedro de Pablos-Velasco ,&nbsp;María M. Trujillo-Martín","doi":"10.1016/j.endien.2023.08.007","DOIUrl":"10.1016/j.endien.2023.08.007","url":null,"abstract":"<div><h3>Background</h3><p>Percutaneous ethanol injection (PEI) has been shown to be a valuable treatment for thyroid nodular pathology and metastatic cervical adenopathies.</p></div><div><h3>Objective</h3><p>To evaluate the effectiveness, safety, and cost-effectiveness of PEI in thyroid nodular pathology and metastatic cervical adenopathies.</p></div><div><h3>Methods</h3><p>A systematic review (SR) using meta-analysis was conducted on the effectiveness and safety of PEI. A SR on cost-effectiveness was also performed. The SRs were conducted according to the methodology developed by the Cochrane Collaboration with reporting in accordance with the PRISMA statement. A cost-minimization analysis was carried out using a decision tree model. Assuming equal effectiveness between two minimally invasive techniques (PEI and radiofrequency ablation (RFA)), the model compared the costs of the alternatives with a horizon of six months and from the perspective of the Spanish National Health System.</p></div><div><h3>Results</h3><p>The search identified three RCTs (<em>n</em> <!-->=<!--> <!-->157) that evaluated PEI versus RFA in patients diagnosed with benign thyroid nodules: ninety-six patients with predominantly cystic nodules and sixty-one patients with solid nodules. No evidence was found on other techniques or thyroid nodular pathology. No statistically significant differences were observed between PEI and RFA in volume reduction (%), symptom score, cosmetic score, therapeutic success and major complications. No economic evaluations were identified. The cost-minimization analysis estimated the cost per patient of the PEI procedure at €326 compared to €4781 for RFA, which means an incremental difference of −€4455.</p></div><div><h3>Conclusions</h3><p>There are no differences between PEI and RFA regarding their safety and effectiveness, but the economic evaluation determined that the former option is cheaper.</p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 9","pages":"Pages 572-583"},"PeriodicalIF":1.9,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138300400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypopituitarism after traumatic brain injury in adults: Clinical guidelines of the neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition (SEEN) 成人创伤性脑损伤后垂体功能减退:西班牙内分泌与营养学会(SEEN)神经内分泌领域的临床指南。
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-01 DOI: 10.1016/j.endien.2023.11.002
Eva Fernández Rodriguez , Rocío Villar Taibo , Ignacio Bernabeu

Traumatic brain injury (TBI) is associated with hypopituitarism with a variable incidence, depending on the time and methods used to diagnosis, and on factors related to the trauma, such as its severity, its anatomical location and the drugs used in the acute phase. The pituitary gland can be damaged directly by the impact or secondary to factors such as ischemia, inflammation, excitotoxicity or immunity. In acute phases ACTH deficiency is the most relevant, since failure to detect and treat it can compromise the patient's life. Clinical manifestations are typical of each hormone deficient axes, although the combination hypopituitarism-trauma has been associated with cognitive deterioration, worse metabolic profile and greater impairment of quality of life. One of the clinical challenges is to determine which patients benefit from a systematic hormonal evaluation, and therefore from hormone replacement, and what is the appropriate time to do so and the most suitable diagnostic methods.

创伤性脑损伤(TBI)与垂体功能减退有关,其发病率不同,取决于诊断的时间和方法,以及与创伤相关的因素,如创伤的严重程度、解剖位置和急性期使用的药物。垂体可直接受到影响或继发于缺血、炎症、兴奋性毒性或免疫等因素。在急性期ACTH缺乏是最相关的,因为未能发现和治疗它可能危及患者的生命。临床表现是每个激素缺乏轴的典型表现,尽管垂体功能低下-创伤合并与认知能力下降、代谢谱恶化和生活质量更大的损害有关。临床面临的挑战之一是确定哪些患者从系统的激素评估中受益,从而从激素替代中获益,以及什么时候进行激素替代和最合适的诊断方法。
{"title":"Hypopituitarism after traumatic brain injury in adults: Clinical guidelines of the neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition (SEEN)","authors":"Eva Fernández Rodriguez ,&nbsp;Rocío Villar Taibo ,&nbsp;Ignacio Bernabeu","doi":"10.1016/j.endien.2023.11.002","DOIUrl":"10.1016/j.endien.2023.11.002","url":null,"abstract":"<div><p><span><span><span>Traumatic brain injury<span> (TBI) is associated with hypopituitarism with a variable incidence, depending on the time and methods used to diagnosis, and on factors related to the trauma, such as its severity, its anatomical location and the </span></span>drugs<span> used in the acute phase. The pituitary gland<span><span> can be damaged directly by the impact or secondary to factors such as ischemia, inflammation, </span>excitotoxicity or immunity. In acute phases </span></span></span>ACTH<span> deficiency is the most relevant, since failure to detect and treat it can compromise the patient's life. Clinical manifestations are typical of each hormone deficient axes, although the combination hypopituitarism-trauma has been associated with cognitive deterioration, worse metabolic profile and greater impairment of </span></span>quality of life. One of the clinical challenges is to determine which patients benefit from a systematic hormonal evaluation, and therefore from hormone replacement, and what is the appropriate time to do so and the most suitable diagnostic methods.</p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 9","pages":"Pages 584-591"},"PeriodicalIF":1.9,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136399902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to handle HMG-CoA lyase deficiency and type 1 diabetes? A challenging case report 如何处理HMG-CoA裂解酶缺乏症和1型糖尿病?一个具有挑战性的案例报告。
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-01 DOI: 10.1016/j.endien.2023.11.004
André Morais , Teresa Pinheiro , Ana Sofia Figueiredo , Cíntia Castro Correia , Teresa Campos , Esmeralda Rodrigues , Elisa Leão Teles
{"title":"How to handle HMG-CoA lyase deficiency and type 1 diabetes? A challenging case report","authors":"André Morais ,&nbsp;Teresa Pinheiro ,&nbsp;Ana Sofia Figueiredo ,&nbsp;Cíntia Castro Correia ,&nbsp;Teresa Campos ,&nbsp;Esmeralda Rodrigues ,&nbsp;Elisa Leão Teles","doi":"10.1016/j.endien.2023.11.004","DOIUrl":"10.1016/j.endien.2023.11.004","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 9","pages":"Pages 609-611"},"PeriodicalIF":1.9,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138300398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult female with severe decompensation of tyrosinaemia type 1 that responds to heme treatment 对血红素治疗有反应的1型酪氨酸血症严重失代偿的成年女性。
IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-01 DOI: 10.1016/j.endien.2023.07.005
Elena Casademunt-Gras , Analia Ramos , Sabina Ruiz , Mariona Martin , Clara Joaquín
{"title":"Adult female with severe decompensation of tyrosinaemia type 1 that responds to heme treatment","authors":"Elena Casademunt-Gras ,&nbsp;Analia Ramos ,&nbsp;Sabina Ruiz ,&nbsp;Mariona Martin ,&nbsp;Clara Joaquín","doi":"10.1016/j.endien.2023.07.005","DOIUrl":"10.1016/j.endien.2023.07.005","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 9","pages":"Pages 612-613"},"PeriodicalIF":1.9,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138300397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrinologia Diabetes Y Nutricion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1